期刊文献+

Cyclin B1蛋白在血管瘤组织中的表达 被引量:8

EXPRESSION OF CYCLIN B1 PROTEIN IN HEMANGIOMA TISSUES
下载PDF
导出
摘要 目的 检测CyclinB1蛋白在皮肤血管瘤组织中的表达 ,探讨CyclinB1在血管瘤发生、发展中的作用及意义。方法 采用免疫组织化学S P法检测增生期血管瘤、退化期血管瘤及正常皮肤组织 (各 2 0例 )中CyclinB1蛋白的表达。结果 在增生期血管瘤、退化期血管瘤和正常皮肤组组织中 ,CyclinB1蛋白免疫组织化学阳性反应颗粒的平均光密度分别为 :0 14 6± 0 0 16 ,0 0 79± 0 0 18,0 0 6 8± 0 0 2 1;阳性面积率分别为 :0 5 38± 0 0 6 5 ,0 2 0 4± 0 0 79,0 176±0 0 5 4。增生期血管瘤与退化期血管瘤、正常皮肤组分别相比 ,CyclinB1蛋白阳性表达的平均光密度和阳性面积率均有极显著性差异 (P <0 0 0 1) ,退化期血管瘤与正常皮肤组之间 ,CyclinB1蛋白阳性表达的差异无显著性 (P >0 0 5 )。结论 Cy clinB1蛋白在血管瘤发生发展和毛细血管内皮细胞的异常过度增生中起着重要的作用。 Objective To investigate the expressionof Cyclin B1 protein and its role in the carcinogenesis and development of hemangioma. Method The expressionsof Cyclin B1 protein in hemangioma tissues at the proliferative and incolutional stages (40 cases) and in normal skin tissues (20cases) weredetected by immunohistochemistryand image analysis. Result In proliferative hemangioma, involutional hemangioma and normal skin tissues, the average optical density of Cyclin B1 protein positive immunostaining was 0.146±0.016,0.079±0.018,0.068±0.021, and the positive rate was 0.538±0.065,0.204±0.079,0.176±0.054, respectively. The Cyclin B1 protein positive expressionin proliferative hemangioma tissues showed significant differences from that in involutional hemangiomatissue and normal skin tissues, ( P <0.001). No statistically significant difference in Cyclin B1 expressionwasobserved between involutional hemangioma tissues and normal skin tissues ( P >0.05). Conclusion Cyclin B1 may play a role in the carcinogenesis and development of hemangioma.
出处 《中国组织化学与细胞化学杂志》 CAS CSCD 2003年第3期259-262,共4页 Chinese Journal of Histochemistry and Cytochemistry
基金 国家自然科学基金资助项目 (30 2 71345 ) 湖北省科技攻关课题资助 (30 1130 6 5 6 )
关键词 CyclinB1蛋白 血管瘤 组织 表达 细胞周期素B1 免疫组织化学 皮肤肿瘤 Hemangioma Cyclin B1 Immunohistochemistry
  • 相关文献

参考文献7

  • 1Marchuk DA.Pathogenesis of hemangioma[J],2001(06).
  • 2Doree M;Hunt T.From Cdc2 to Cdk1: when did the cell cycle kinase join its cyclin partner?[J],2002(115).
  • 3Murry AW.Creative blocks: cell-cycle checkpoints and feedback controls[J],1992(02).
  • 4Hwang A;Maity A;McKenna WG.Cell cycle-dependent regulation of the cyclin B1 promoter[J],1995(47).
  • 5Kuhling H;Alm P;Olsson H.Expression of cyclins E, A, and B, and prognosis in lymph node-negative breast cancer[J],2003(04).
  • 6Korenaga D;Takesue F;Yasuda M.The relationship between cyclin B1 overexpression and lymph node metastasis in human colorectal cancer[J],2002(131).
  • 7Hunter T;Pines J.Cyclins and cancer II:Cyclin D and CDK inhibitors come of age[J],1994(04).

同被引文献98

引证文献8

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部